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Background: In spite of the World Health Organization recommendations for the treatment of malaria, febrile
patients are still infrequently tested and erroneously treated for malaria. This study aimed to investigate the
adherence to malaria national protocol for the management of malaria among under five years old children.
Methods: A cross sectional hospital-based study was conducted during the period from September through
December 2013 among febrile children below the age of five years attending the outpatient department of
Omdurman Children Hospital, Sudan. Demographic, clinical and laboratory data [blood film, rapid diagnostic test
(RDTs), haemoglobin, WBCs and chest X ray] and anti-malarials and/or antibiotics prescription were recorded.
Results: A total of 749 febrile children were enrolled. The mean (SD) age was 37.51 (41.6) months. Less than a
half, (327, 43.7%) of children were investigated for malaria using microscopy (271, 82.9%), RDT (4, 1.2%) or both
(52, 15.9%). Malaria was not investigated for more than a half, (422, 56.3%) however investigations targeting other
causes of fever were requested for them. Malaria was positive in 72 (22%) of the 327 investigated children. Five
(1.6%) out of 255 with negative malaria tests were treated by an anti-malarials. Quinine was the most frequently
prescribed anti-malarials (65, 72.2%) then artemisinin-based combination therapy (ACT) (2, 27.8%). The majority of
the 749 children (655, 87.4%) were prescribed an antibiotic.
Conclusion: There is a poor adherence to malaria management protocol in Sudan among physicians treating
children below five years of age. There was a high rate of antibiotic prescription needs.
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In spite of many measurements, malaria remains a big
public health problem where it is estimated that about a
million deaths and over 400 million malaria cases occur
worldwide each year, with 90% of these deaths occurring
in sub-Saharan Africa [1]. Owing to the spread of Plasmo-
dium falciparum resistant strains in the majority of mala-
ria endemic countries, the World Health Organization
(WHO) recommended artemisinin-based combination
therapy (ACT) for the treatment of uncomplicated P. fal-
ciparum malaria, which is adopted in most of the African* Correspondence: ishagadam@hotmail.com
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unless otherwise stated.countries including Sudan [2]. In 2010, the WHO ex-
panded its recommendations to include laboratory con-
firmation with microscopy or a rapid diagnostic test
(RDT) before initiating anti-malarial therapy [3]. Hence,
the management of fever in African countries underwent
a radical change in the recent years from the presumptive
diagnosis and treatment of fever as malaria to formal
guidelines [3-5]. Due to the spread of multidrug resistant
P. falciparum strains in Sudan, the drug treatment policy
for uncomplicated P. falciparum malaria was changed in
the year 2004 from chloroquine to ACT, where artesunate
plus sulphadoxine/pyrimethamine (AS + SP) and arteme-
ther plus lumefantrine (AL) is the first- and second-line
treatment for uncomplicated P. falciparum malaria,is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Frequency (%) of symptoms encountered and
requested laboratory characteristics in febrile children










Runny nose 28 (3.7)
Laboratory characteristics
Blood film for malaria 322 (42.9)
Leucocytes 415 (55.3)
Haemoglobin 313 (41.7)
Chest X-Ray 133 (17.8)
Rapid diagnostic test 66 (8.8)
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febrile patients are still infrequently tested for malaria
[8,9]. A considerable number of patients are treated for
malaria despite negative test results and high a frequency
antibiotic prescription for those patients was reported as
well [10-12]. In this context, it is vital to investigate the
prescription practices of health care providers in Sudan
for reasonably accurate information about the causes of
childhood death is part of the Target of Millennium
Development Goal 4 [13]. Furthermore, information on
success/failure of the national malaria programmes in
endemic countries will help augment the new plan of the
WHO towards malaria elimination since one of opera-
tional requirements for elimination is “all malaria cases
are microscopically confirmed and treated according to
national policy” [14]. The aim of this study was to investi-
gate the adherence to malaria national protocol for the
management of malaria among under five years old
children.
Methods
A hospital-based cross sectional study was conducted in
Omdurman Children Hospital, during the period from
September through December 2013. Omdurman is one
of the three cities of the tripartite metropolitan capital,
Khartoum. Malaria transmission in Khartoum is recog-
nized as low in intensity [15]. Medical doctors (graduate
of medical colleges) are managing children at OCEH are
residents who are enrolled in postgraduate training
supervising general practitioners who completed more
than one year after internship and house physicians or
interns who are doing their assessment for permanent
registration as general practitioners. The hospital is
equipped with a well-prepared laboratory with malaria
diagnosis facilities; thin and thick blood films and RDT
performed by well-trained technicians.
Population is children under the age of five years who
presented with fever to the outpatient/emergency clinics
at OCEH. It was assumed that the proportion of febrile
under-five year old children who had to receive prescrip-
tions in accordance with the guidelines of treatment of
malaria was not known before the study. However, a
random sample of 740 children was selected to calculate
the proportion of febrile children within 3 percentage
points of the true proportion, assuming the true propor-
tion was 70% and that 10% of children would not be re-
spond or have complete data.
During the study period all febrile children ≤5 years of
age were included. Using a structured questionnaire, in-
formation on age, gender, whether the child complained
of cough, runny nose, difficulty of breathing, vomiting,
diarrhea, convulsion and inactivity were prospectively re-
corded at recruitment. A general practitioner or a house
physician initially assessed children. Axillary temperaturewas recorded. Whether, microscopy for malaria, RTD
white blood cell count and the chest X-ray were requested
and the results, if available, were recorded. Finally, the
treating physicians’ prescriptions of anti-malarials and/or
antibiotics were recorded.
Ethics
Children’s guardians were informed about the purposes
of the study and they signed a written informed consent
prior to enrolment. The study received ethical approval
from the ethical committee of the hospital.
Statistics
Data were entered into computer using SPSS for Window,
version 20 (SPSS Inc., Chicago, Illinois). The mean and
standard deviation were calculated for numerical data and
frequency distribution was calculated for nominal or
ordinal variables. Univariate and multivariate logistic re-
gressions were used where anti-malarials and combined
anti-malarials/antibiotics prescriptions were dependent
variables and demographic variables age and gender, cli-
nical variables and laboratory values were the independent
variables. The results were expressed as odds ratios (ORs)
and 95% confidence intervals (95% CIs). A p value < 0.05
was considered significant.
Results
A total of 749 febrile children at the mean (SD) age of
37.51 (41.68) months were enrolled to the study. Males/fe-
male ratio was 1.35 [430, (57.4%) vs. 319 (42.6%)]. Table 1
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fever and the laboratory characteristics requested by the
treating clinicians.
Around two fifth (327, 43.7%) of these children were
investigated for malaria using microscopy (271, 82.9%),
RDT (4, 1.2%) or both (52, 15.9%). Other investigations
were requested beside malaria for 96 (12.8%) children,
these were; white blood cell count (53), haemoglobin
(41) and chest X-ray (2). Malaria was not investigated
for over half 422 (56.3%) of the children however,
haemoglobin concentration, white blood cell count and
chest X-ray were requested for (313, 74.2%), 415/422
(415, 98.3%) and (44, 10.4%) of these 422 children, re-
spectively. Malaria was positive in 72 (22%) of the 327
investigated children, 63 of them were positive by mi-
croscopy, four by RDT and five were by both.
The majority of (67, 93.1%) of malaria positive 72 chil-
dren received anti-malarials whereas, five (6.9%), were
not. Malaria was negative in 255 (78%) of the 327 tested
children however, 5 (2%) of them received anti-malarials.Figure 1 Febrile children management flowchart at Omdurman HospAmong children who were not tested for malaria (n = 422)
but tested for other causes of fever, 10 (2.4%) were pre-
sumptively treated as malaria (Figure 1).
Quinine was the most frequently prescribed anti-
malarial (as intravenous infusion) for 65 (72.2%) cases,
followed by AS+ SP and AL for 25 (27.8%) cases. Forty-
two (64.6%) out of 65 patients who were treated by
quinine, had no any sign of severe malaria.
In a logistic regression, while none of the demographic
and clinical characters associated with physicians’ anti-
malarials prescription, investigating malaria (via blood
film/RDT) was the only variable associated with phy-
sicians’ anti-malarials prescription (Table 2). The vari-
ables age, cough, breathlessness, vomiting, seizure, the
white cell count and microscopy requests were associa-
ted with combined anti-malarial/antibiotic prescription
however when adjusting for all variables in a multiva-
riate model, only age, vomiting, seizure, white cell count
and haemoglobin level were associated the combined
anti-malarials/antibiotics prescription (Table 3).ital, Sudan.
Table 2 Demographic and laboratory characters associated with anti-malarial prescription for febrile less than
5-year-old children at Omdurman Hospital, Sudan using univariate and multivariate analyses
Variables Univariate Multivariate
OR 95% CI P value OR 95% CI P value
Age 1.02 1.01-1.02 <0.001 0.98 0.95- 1.01 0.159
Gender 1.34 0.86-2.08 0.199 0.32 0.07- 1.48 0.144
Cough 0.26 0.16-0.43 <0.001 0.59 0.11- 3.10 0.538
Runny nose 1.23 0.42-6.63 0.707 5.76 0.03- 1016 0.506
Breathlessness 0.22 0.10-0.46 <0.001 0.96 0.09- 10.21 0.973
Vomiting 2.1 1.29-3.39 0.003 1.09 0.25- 4.82 0.905
Diarrhoea 0.81 0.41-1.64 0.573 1.43 0.19- 10.64 0.725
Seizure 1.98 1.15-3.42 0.014 5.53 0.89- 34.2 0.066
Lethargy 1.46 0.90-2.35 0.122 0.66 0.03- 16.99 0.801
Temperature 1.00 0.88-1.13 0.998 1.14 0.61- 2.11 0.691
Leucocytes 1.00 1.01-1.05 0.036 1.00 0.99- 1.00 0.991
Chest X-ray 0.93 0.70-1.25 0.645 0.93 0.24- 3.61 0.911
Positive malaria 6.33 3.7-10.8 <0.001 22.34 12.3- 40.5 <0.001
Haemoglobin 0.94 0.85-1.04 0.235 0.82 0.63-1.06 0.136
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prescribed an antibiotic. Antibiotic prescription was re-
gardless of the status of malaria testing.
Discussion
In malaria endemic areas including Sudan, the WHO and
the National Malaria Programme recommended parasite-
based malaria diagnosis by light microscopy or RDTs.
Positive result is the only indication for anti-malarials
treatment whereas negative cases “should be reassessed
for other common causes of fever” [2,6,16,17].Table 3 demographic and laboratory characters associated w
febrile less than 5-year-old children at Omdurman Hospital, S
Variables Univariate
OR 95% CI P
Age 1.0 1.00-1.02 0.
Gender 1.3 0.68-2.48 0.
Cough 4.1 1.91-8.71 <
Runny nose 1.5 0.19-11.4 0.
Breathlessness 3.6 1.26-10.26 0.
Vomiting 0.4 0.22-0.84 0.
Diarrhoea 1.0 0.38-2.66 0.
Seizure 0.3 0.14-0.58 0.
Inactivity 0.5 0.13-1.56 0.
Leucocytes 1.0 1.01-1.00 0.
Chest X-ray 0.9 0.60-1.42 0.
Positive malaria 4.7 2.22-10.14 <
Haemoglobin 0.9 0.77-1.02 0.This study investigated physicians’ adherence to mala-
ria management guidelines in a reference setting in
Khartoum, Sudan. Less than a half of all febrile children
were tested by a parasite-based test for malaria though
all should have been tested according to the manage-
ment protocol [6]. Testing is a criterion of ACT-based
management policy in addition to treatment of test-
positive patients and not treating negatively tested pa-
tients [18]. Adherence to testing in this study was less
than the adherence that reported (43.67% vs. 45.8%) by
Abelgadir et al. two years ago in a cluster-sample surveyith combined anti-malarial/antibiotic prescription for
udan using univariate and multivariate analyses
Multivariate
value OR 95% CI P value
001 1.0 1.00-1.03 0.012
428 0.8 0.23-2.57 0.675
0.001 1.3 0.33-5.17 0.702
693 11.4 0.00-1.00 0.999
016 0.65 0.09-4.21 0.649
014 0.2 0.06-0.70 0.012
975 1.5 0.27-8.28 0.646
001 0.2 0.06-0.87 0.030
221 0.9 0.09-9.13 0.920
008 1.0 1.00-1.00 0.003
720 1.05 0.62-1.78 0.863
0.001 1.5 0.42-5.23 0.549
097 0.8 0.64-0.94 0.010
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ever comparable to a Kenyan setting and indeed higher
than evaluations in other countries [19-21]. The treating
practitioners in this setting were physicians compared to
the earlier cluster survey in Sudan and the aforemen-
tioned African facilities. Physicians might depend on
their clinical sense more than testing. Nevertheless, tes-
ting was not requested at all in the majority of febrile
children in this study, possibly physicians were investi-
gating them for other causes of fever. Although most of
the requested malaria tests in this study were micros-
copy, dual request for both microscopy and RDT was
observed in a proportion of children possibly because
physician were not relying on RCT for malaria diagnosis.
Although the majority of tested positive children were
treated for malaria, almost 7% of them were not owing to
the reluctance of physicians to treat possibly because of
the low specificity of microscopy at hospitals in Sudan and
their reliance on clinical judgment [22]. A better rate
of adherence was reported from Uganda and Tanzania
[16,17]. Prescription rate for negatively tested children in
this study was far better than the 56% rate reported from
Tanzania [23]. An even higher proportion of parasite
negative patients receiving anti-malarial was conveyed
from Burkina Faso [24]. Anti-malarial rate of prescription
of 2% in non-malaria cases in this study was lower than
Bottieau et al., one of the favourable reports [25]. The var-
ied reports may be attributed to different study designs,
means of data collection and overemphasis on malaria
diagnosis and treatment during training of health pro-
viders [26]. Furthermore, the conflicting overlap in IMCI
programme and WHO guidelines for treatment of malaria
may contribute to the varied prescription behavior among
clinical practitioners [3,27].
The most striking was that injectable quinine was
unduly used in this cohort for the treatment of 72.2% of
children with non-severe malaria instead of the re-
commended first-line therapy, ACT. This highly discor-
dant practice was almost double the figure reported by
Abdelgadir et al. as 36% used injectable artemether mono-
therapy rather than quinine [10]. Nevertheless, stock-outs
of ACT were reported in their study, a possible factor in
faulty prescription. In a Kenyan survey, non-recommended
treatments comprising either quinine monotherapy or a
combination of anti-malarials and quinine was reported
to become uncommon in children below five years of
age and mainly prescribed for older children and adults
where lower adherence for test positive patients was ob-
served [28]. In one report, only 30% of patients were
treated with ACT, suggesting that targeting of ACT
would be poor even if microscopy was accurate. The
findings may suggest that practitioners may clinically in-
tend to rule out malaria in febrile children despite prac-
tice inappropriateness and inconsistency with Sudaneseguidelines, possibly an IMCI effect on clinician’s pre-
scription [6,27].
Almost 2.5% of patients not tested for malaria were
treated by an anti-malarial in this cohort. This rate of pre-
sumptive treatment of malaria was less than the 19.2%
rate reported by Zurovac et al. and Manyando et al.
[28,29]. This group of practitioners might depend on their
clinical sense and perhaps not trusting laboratory results,
an argument that may be possibly augmented by the dual
request of both RDT and microscopy for the same patient
in this report or perhaps they were still following the
IMCI guidelines.
Near to 88% of children in this study were prescribed
an antibiotic whether or not tested positive for malaria.
Njozi et al. found no significant difference in antibiotics
co-prescription with anti-malarial between those tested
positive for malaria and not tested in febrile patients in
Tanzania [23]. However, Ugandan patients who received
an antibiotic had lower odds of not being prescribed
anti-malarials [16]. Different reports may be attributed
to different policies and guidelines adopted by the health
authorities in these countries.
This study however has numerous limitations. First, the
hospital setting is a site of referral for sick children and
thus results cannot be generalized as for all settings in the
country. Second, prior antibiotic and anti-malarial treat-
ment were not identified in this cohort as it may affect the
practitioner’s prescription decision. Third, follow-up and
patients outcome data was not assessed. Finally, observer
bias cannot be ruled out although an expert clinician had
collected the data.Conclusion
Despite a decade adoption of “test and treat” policy for
malaria in this country, there is still poor adherence to
malaria management protocol in Sudan among physicians
treating children below five years of age. The poor adher-
ence materializes in low testing rate, faulty prescription of
anti-malarial to test-negative children and ominously
about three quarters of children with malaria were treated
with non-recommended anti-malarials. There is a high
rate of antibiotic prescription, which needs further studies
to clarify the drive behind such clinical behaviour. The
ambiguity of different guidelines (malaria programme/
IMCI) may contribute to the confusion of prescription
among health workers.
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